With the estimated cost of bringing a drug to market at $2.5 billion and the probability of success of getting to the market from phase 1 at less than 10%, clinical operations have never faced a more challenging environment than now. A typical phase III trial generates 900,000 data points, and companies struggle to make sense of this deluge of information. Monitoring a trial based on routine visits is costly, and 100% source data verification does not contribute to data quality value, while accounting for upto 25% of the trial cost.

Navitas Life Sciences blends domain knowledge and technology expertise to create immense value for your organization. Our global clinical consultants apply their extensive expertise and knowledge to guide sponsors to achieve their strategic objectives through best practices. With over 30 years of experience of supporting Life Sciences companies, breakthrough insights gained through our industry network forums, models for success, and proven structured approaches, Navitas Life Sciences serves as your trusted strategic advisor.

Engagements begin with a detailed current state assessment to prioritize improvement opportunities and continue beyond pragmatic recommendations to include detailed solution design and implementation. This includes managing the change, developing / revising controlled documents, incorporating revised responsibilities into role descriptions, and developing training plans and materials for roll-out across functional stakeholders. We include inputs from your subject matter experts, who have deep institutional knowledge, prominently on project teams. Suggested  improvements are implemented smoothly to ensure project benefits continue to be realized beyond the end of our contractual engagement.